# Contact MD/TB-500 | TB-500 Research Editorial Feedback

> Contact the MD/TB-500 editorial team for citation corrections, research updates, or general feedback on the TB-500 peer-reviewed literature summaries.

## Contact the Editorial Team

MD/TB-500 publishes summaries of the peer-reviewed research literature on TB-500 and thymosin beta-4. This is an editorial project — not a clinic, not a vendor, not a prescription service.

We accept the following types of correspondence:

**Citation corrections.** If you identify an error in a citation — incorrect PMID, incorrect DOI, misattributed finding — please send the corrected reference with the PubMed or journal URL. We update the literature record promptly.

**Research updates.** If a new study relevant to TB-500 or thymosin beta-4 has been published, we welcome notification with the DOI or PubMed link. We do not accept manuscripts for review and we do not provide peer review services.

**General editorial feedback.** Factual corrections, readability feedback, or questions about our editorial methodology are welcome.

We do not respond to: requests for medical advice, dosing recommendations, supplier referrals, or vendor partnership inquiries. No clinical consultation services are offered or implied by this publication.

Use the form below to send a message. We aim to respond to substantive editorial correspondence within five business days. Responses to clinical or vendor inquiries are not provided.

---

The TB-500 record: Ac-LKKTETQ, amber-phosphor, dumped to stdout from the peer-reviewed literature — no clinic, no prescription, no commercial position.